Bosentan
Brand name: Tracleer
Bosentan comes in 17 pill versions in our database, in 3 strengths, from 8 manufacturers. Check the imprint to tell them apart.
Bosentan pill images
32 mg 3 pills
- 32 Bosentan 32 mg White, clover, 10 mm Used for high blood pressure in the lungs
- 32 Bosentan 32 mg Yellow, round, 10 mm Used for high blood pressure in the lungs
- 1508 Bosentan 32 mg White, round, 10 mm Used for high blood pressure in the lungs
62.5 mg 7 pills
- WPI 62 5 Bosentan 62.5 mg Orange, round, 6 mm Used for high blood pressure in the lungs
- 446 Bosentan 62.5 mg Pink, round, 7 mm Used for high blood pressure in the lungs
- 945 Bosentan 62.5 mg Orange, round, 6 mm Used for high blood pressure in the lungs
- 62 5 Bosentan 62.5 mg White, round, 6 mm Used for high blood pressure in the lungs
- 62,5 Bosentan Monohydrate 62.5 mg Orange & white, round Used for high blood pressure in the lungs
- B 62.5 Bosentan Monohydrate 62.5 mg Orange & white, round Used for high blood pressure in the lungs
- 945 Bosentan Monohydrate 62.5 mg Orange & white, round Used for high blood pressure in the lungs
125 mg 7 pills
- WPI 125 Bosentan 125 mg Orange, oval, 11 mm Used for high blood pressure in the lungs
- 447 Bosentan 125 mg Pink, oval, 11 mm Used for high blood pressure in the lungs
- 946 Bosentan 125 mg Orange, oval, 11 mm Used for high blood pressure in the lungs
- 125 Bosentan 125 mg White, oval, 11 mm Used for high blood pressure in the lungs
- 125 Bosentan Monohydrate 125 mg Orange & white, oval Used for high blood pressure in the lungs
- B 125 Bosentan Monohydrate 125 mg Orange & white, oval Used for high blood pressure in the lungs
- 946 Bosentan Monohydrate 125 mg Orange & white, oval Used for high blood pressure in the lungs
What is Bosentan used for?
Bosentan is used for high blood pressure in the lungs.
- Medicine type
- Endothelin receptor antagonist
Official uses from the US prescribing label
Bosentan tablets are indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1):
- in adults to improve exercise ability and to decrease clinical worsening. Studies establishing effectiveness included predominantly patients with WHO Functional Class II-IV symptoms and etiologies of idiopathic or heritable PAH (60%), PAH associated with connective tissue diseases (21%), and PAH associated with congenital heart disease with left-to-right shunts (18%).
- in pediatric patients aged 3 years and older with idiopathic or congenital PAH to improve pulmonary vascular resistance (PVR), which is expected to result in an improvement in exercise ability.
From the FDA-approved label on DailyMed (published Jun 04, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.